Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study

J Infect. 2023 Apr;86(4):406-409. doi: 10.1016/j.jinf.2023.01.026. Epub 2023 Jan 23.
No abstract available

Keywords: Febrile; Hematological diseases; Neutropenia; Polymyxin B; Success rate.

Publication types

  • Observational Study
  • Multicenter Study
  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Drug Therapy, Combination
  • Febrile Neutropenia* / drug therapy
  • Fever / drug therapy
  • Hematologic Diseases*
  • Hematologic Neoplasms* / drug therapy
  • Humans
  • Polymyxin B / adverse effects
  • Prospective Studies

Substances

  • Polymyxin B
  • Antifungal Agents
  • Anti-Bacterial Agents